Anwaar Saeed, Greg Yothers, Shannon L. Puhalla, Priya Rastogi, Tanner Freeman, Melissa Divya Mathias, Frank A. Seebach, Norman Wolmark, Thomas J. George. "NSABP FC-13 (EMPIRE): A phase II platform study of cemiplimab monotherapy or cemiplimab-based combinations in patients with colorectal cancer and minimal residual disease (MRD) after definitive therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3685